Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04139564 · ClinicalTrials.gov registry record · NA
EaseVRx for the Reduction of Chronic Pain and Opioid Use
A NA study, sponsored by AppliedVR.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT04139564 is a NA study that has completed, run by AppliedVR. The registered enrollment target is 108 participants.
The verdict
NCT04139564, a NA study, has completed, sponsored by AppliedVR.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
EaseVRx, a software-based virtual reality (VR) medical device, is intended to offer users a prescription pain management tool that manages the symptoms associated with chronic pain and reduces or eliminates the risk of opioid dependence. The investigators will conduct a proof-of-concept randomized study to assess the feasibility and efficacy of using EaseVRx as a 56-day, VR-based, at-home program among 100 chronic low back pain patients by gathering pilot data on the efficacy of the intervention in decreasing pain, reducing opioid/non-opioid pharmacotherapy, and improving pain-related quality of life.
Interventions
- DEVICE EaseVRx headset
- DEVICE Active control VR sham program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2021-01-11 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04139564
The ClinicalTrials.gov registry entry for NCT04139564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AppliedVR, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EaseVRx headset is the first listed.
NCT04139564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04139564 about?
NCT04139564 is a clinical study titled "EaseVRx for the Reduction of Chronic Pain and Opioid Use". EaseVRx, a software-based virtual reality (VR) medical device, is intended to offer users a prescription pain management tool that manages the symptoms associated with chronic pain and reduces or eliminates the risk of opioid dependence. The investigators will conduct a proof-of-concept randomized s...
What is the current status of trial NCT04139564?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2021-01-11. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04139564?
The interventions under investigation include: EaseVRx headset (DEVICE), Active control VR sham program (DEVICE).
Who is sponsoring clinical trial NCT04139564?
This trial is sponsored by AppliedVR, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.